Cargando…

Farnesol Ameliorates Demyelinating Phenotype in a Cellular and Animal Model of Charcot-Marie-Tooth Disease Type 1A

Charcot-Marie-Tooth disease (CMT) is a genetically heterogeneous disease affecting the peripheral nervous system that is caused by either the demyelination of Schwann cells or degeneration of the peripheral axon. Currently, there are no treatment options to improve the degeneration of peripheral ner...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Na-Young, Kwak, Geon, Doo, Hyun-Myung, Kim, Hye-Jin, Jang, So-Young, Lee, Yun-Il, Choi, Byung-Ok, Hong, Young-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928981/ https://www.ncbi.nlm.nih.gov/pubmed/34889893 http://dx.doi.org/10.3390/cimb43030138

Ejemplares similares

A Mutation in PMP2 Causes Dominant Demyelinating Charcot-Marie-Tooth Neuropathy
por: Hong, Young Bin, et al.
Publicado: (2016)

Foot Deformity in Charcot Marie Tooth Disease According to Disease Severity
por: Joo, So Young, et al.
Publicado: (2011)

Gait parameters as tools for analyzing phenotypic alterations of a mouse model of Charcot-Marie-Tooth disease
por: Hwang, Sun Hee, et al.
Publicado: (2021)

Targeted PMP22 TATA-box editing by CRISPR/Cas9 reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice
por: Lee, Ji-Su, et al.
Publicado: (2020)

Mechanisms and treatment strategies of demyelinating and dysmyelinating Charcot-Marie-Tooth disease
por: Hertzog, Nadège, et al.
Publicado: (2023)

Charcot-Marie-Tooth Disease: Seventeen Causative Genes
por: Lee, Jung-Hwa, et al.
Publicado: (2006)

Phenotypic heterogeneity in patients with NEFL‐related Charcot–Marie–Tooth disease
por: Kim, Hye Jin, et al.
Publicado: (2022)

Gait Pattern in Charcot-Marie-Tooth Disease Type 1A According to Disease Severity
por: Park, Jihyun, et al.
Publicado: (2023)

Clinical and Neuroimaging Features in Charcot-Marie-Tooth Patients with GDAP1 Mutations
por: Kim, Hyun Su, et al.
Publicado: (2021)

Charcot-Marie-Tooth 1A Concurrent with Schwannomas of the Spinal Cord and Median Nerve
por: Kwon, Joo Young, et al.
Publicado: (2009)

Whole-genome sequencing in clinically diagnosed Charcot–Marie–Tooth disease undiagnosed by whole-exome sequencing
por: Kim, Young-gon, et al.
Publicado: (2023)

Preimplantation genetic diagnosis for Charcot-Marie-Tooth disease
por: Lee, Hyoung-Song, et al.
Publicado: (2013)

Diagnosis of Charcot-Marie-Tooth Disease
por: Banchs, Isabel, et al.
Publicado: (2009)

Electrophysiological Evaluation of Chronic Inflammatory Demyelinating Polyneuropathy and Charcot-Marie-Tooth Type 1: Dispersion and Correlation Analysis
por: Kang, Ji Hyuk, et al.
Publicado: (2013)

Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient
por: Koros, Christos, et al.
Publicado: (2013)

Muscle fat quantification using magnetic resonance imaging: case–control study of Charcot–Marie–Tooth disease patients and volunteers
por: Kim, Hyun Su, et al.
Publicado: (2019)

Clinical and Neuroimaging Features in Charcot–Marie–Tooth Patients with GNB4 Mutations
por: Kwon, Hye Mi, et al.
Publicado: (2021)

A compound heterozygous mutation in HADHB gene causes an axonal Charcot-Marie-tooth disease
por: Hong, Young Bin, et al.
Publicado: (2013)

Novel homozygous mutations in Pakistani families with Charcot–Marie–Tooth disease
por: Kanwal, Sumaira, et al.
Publicado: (2021)

Peripheral Myelin Protein 22 Gene Mutations in Charcot-Marie-Tooth Disease Type 1E Patients
por: Jung, Na Young, et al.
Publicado: (2022)

Hidden hearing loss in patients with Charcot-Marie-Tooth disease type 1A
por: Choi, Ji Eun, et al.
Publicado: (2018)

A dysfunctional endolysosomal pathway common to two sub-types of demyelinating Charcot–Marie–Tooth disease
por: Edgar, James R., et al.
Publicado: (2020)

Charcot–Marie–Tooth disease and intracellular traffic
por: Bucci, Cecilia, et al.
Publicado: (2012)

Noncompaction Cardiomyopathy with Charcot-Marie-Tooth Disease
por: Eltawansy, Sherif Ali, et al.
Publicado: (2015)

Anejaculation in a patient with Charcot–Marie–Tooth
por: Cannarella, Rossella, et al.
Publicado: (2018)

Charcot-Marie-Tooth: From Molecules to Therapy
por: Morena, Jonathan, et al.
Publicado: (2019)

Audiological findings in the Charcot-Marie-Tooth Disease
por: Fukushima, Erika, et al.
Publicado: (2015)

Novel de novo POLR3B mutations responsible for demyelinating Charcot–Marie–Tooth disease in Japan
por: Ando, Masahiro, et al.
Publicado: (2022)

Pathological evidence of demyelination in the recurrent laryngeal, phrenic, and oculomotor nerves in Charcot-Marie-Tooth disease 4F
por: Maeda, Kengo, et al.
Publicado: (2021)

Mutations in the PLEKHG5 gene is relevant with autosomal recessive intermediate Charcot-Marie-Tooth disease
por: Kim, Hyeon Jin, et al.
Publicado: (2013)

Balance and muscle power of children with Charcot-Marie-Tooth
por: Silva, Tais R., et al.
Publicado: (2014)

A SIMPLE explanation for Charcot-Marie-Tooth disease
por: Short, Ben
Publicado: (2012)

ACQUIRED PES CAVUS IN CHARCOT-MARIE-TOOTH DISEASE
por: Maranho, Daniel Augusto, et al.
Publicado: (2015)

Charcot Marie Tooth Disease. A Single Disorder?
por: Fontés, Michel
Publicado: (2018)

Impaired Mitochondrial Mobility in Charcot-Marie-Tooth Disease
por: Schiavon, Cara R., et al.
Publicado: (2021)

Emerging Therapies for Charcot-Marie-Tooth Inherited Neuropathies
por: Stavrou, Marina, et al.
Publicado: (2021)

Anaesthetic implications in patient with Charcot-Marie-Tooth disease
por: Kapoor, Hemlata, et al.
Publicado: (2021)

The Current State of Charcot–Marie–Tooth Disease Treatment
por: Okamoto, Yuji, et al.
Publicado: (2023)

A Rasch Analysis of the Charcot-Marie-Tooth Neuropathy Score (CMTNS) in a Cohort of Charcot-Marie-Tooth Type 1A Patients
por: Wang, Wenjia, et al.
Publicado: (2017)

Perk Ablation Ameliorates Myelination in S63del-Charcot–Marie–Tooth 1B Neuropathy
por: Musner, Nicolò, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fs1kbknl7e86d5mff4j8jkn5uq